Hypertension: IL-1 receptor-induced sodium reabsorption in hypertension


The effects of synbiotic therapy on serum levels of microbiomegenerated uraemic toxins have been assessed in a new study involving predialysis patients with chronic kidney disease (CKD). Data from the SYNERGY trial found that a 6 week prebiotic and probiotic therapeutic protocol favourably modified the stool microbiome in the 31 patients who completed the… (More)
DOI: 10.1038/nrneph.2016.1


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.